2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
Version 1.2 2 4.2 Dose and method of administration Patients should be made aware of the prophylactic nature of therapy with inhaled beclometasone
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Management of Excessive Respiratory Secretions: A Sharing ...
www.fmshk.orgPalliative Medicine Doctors’ Meeting_____HKSPM Newsletter 2007 Dec Issue 3 p 18 adenocarcinoma of lung at a dose 300-500
8. Pharmacologic Approaches to Glycemic Treatment ...
care.diabetesjournals.orgEducationregardingmatchingprandial insulin dosing to carbohydrate intake, premeal glucose levels, and anticipated activity should be considered, and se-
ACNE AGENTS, TOPICAL - ctdssmap.com
www.ctdssmap.comantifungals, topical antiparkinson's agents, cont. antivirals, oral & inhaled bronchodilators, beta agonist clotrimazole 1% cream (rx only) (topical) pramipexole (ir) (oral) acyclovir capsule, tablet (oral) albuterol neb soln 100 mg/20 ml (inhalation)
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.pharma.us.novartis.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TOBI Podhaler is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory
ISMP’s List of High-Alert Medications - ALBOP
www.albop.comInstitute for Safe Medication Practices www.ismp.org Institute for Safe Medication Practices Classes/Categories of Medications adrenergic agonists, IV (e.g., epinephrine)
201-2013: A Practical Approach to Creating Define.XML by ...
support.sas.com5 SC Subcutaneous PR Per rectal SL Sublingual INH Inhaled TOP Topical TD Transdermal TB Transbuccal Other Other, specify NMT Non-Medicinal Therapy
Medication Pass Fundamentals Part 3: Basics of Preparing ...
www.mmlearn.orgRoute Specific Concerns Enteral, Inhaled Medications (lung), Topical, Transdermal, Subcutaneous Injections, Suppositories 5
SIGMA-ALDRICH MATERIAL SAFETY DATA SHEET
terpconnect.umd.eduSIGMA-ALDRICH MATERIAL SAFETY DATA SHEET Date Printed: 03/03/2004 Date Updated: 06/25/2003 Version 1.6 Section 1 - Product and Company Information
MEASLES AEROSOL VACCINE PROJECT - REPORT TO SAGE - …
www.who.intMEASLES AEROSOL VACCINE PROJECT - REPORT TO SAGE 2 equipment, such as the exclusive use of auto-disable syringes and safety boxes, is necessary, but these